Clinical Trials Browser

Phase 2/3 × Recurrence × Temozolomide × Clear all

NCT03970447 2026-05-15

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT02414165 2020-02-07

Toca5

Phase 2/3 Terminated

Astrocytoma, Glioblastoma, Recurrence

NCT00749723 2018-07-20

HIT-REZ-2005

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence